Compound ID | 2069
Synonym(s): Sulfisomezole | sulfamethalazole | sulfamethazole
Class: Antibacterial sulfonamide (sulfa drug)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Sulphonamides are structural analogues of p-aminobenzoic acid and act as competitive inhibitors (and alternate substrates) of dihydropteroate synthase (DHPS) to block the synthesis of folic acid. Primarily bacteriostatic; rapid emergence of resistance. |
Description: | Synthetic sufanilamide derivative; intermediate-acting (8-12 hours). Mostly used in fixed combination with trimethoprim (synergistic combination) for treatment and prophylaxis (oral and iv). |
Year first mentioned: | 1950 |
Development status: | Approved, off-patent, discontinued in most countries as monotherapy |
Chemical structure(s): | |
Canonical SMILES: | CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N |
Isomeric SMILES: | CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N |
InChI: | InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13) |
InChI Key: | JLKIGFTWXXRPMT-UHFFFAOYSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/5329 |
External links: | |
Guide to Pharmacology: | sulfamethoxazole |
Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046889/ |